Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral bloodNatalia Bednarz, Elke Eltze, Axel Semjonow, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 5, 2024
Measurable morphological features of single circulating tumor cells in selected solid tumors-A pilot studyRobert Wenta, Julia Richert, Anna Muchlińska, et al.
Journal of Personalized Medicine|November 27, 2021
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer ProgressionPaulina Nastały, Julia Smentoch, Marta Popęda, et al.
Scientific Reports|August 4, 2021
Transcriptomic landscape of blood platelets in healthy donorsAnna Supernat, Marta Popęda, Krzysztof Pastuszak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Circulating tumor cells in patients with testicular germ cell tumorsPaulina Nastały, Christian Ruf, Pascal Becker, et al.
Oncotarget|January 2, 2018
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortiumEva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, et al.
British Journal of Cancer|September 9, 2020
EGFR as a stable marker of prostate cancer dissemination to bonesPaulina Nastały, Sara Stoupiec, Marta Popęda, et al.
International Journal of Cancer|May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortiumGesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
Clinical Chemistry|June 2, 2022
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate CancerKatharina Besler, Aleksandra Węglarz, Laura Keller, et al.
Oncogene|January 9, 2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesionsFrancesco Pantano, Martine Croset, Keltouma Driouch, et al.
Pageof 4